ICHORtec’s innovative strength is based on “point-of-care” and
“point-of-use” solutions. The entrepreneurial goals are the establishment, development and exploitation of new diagnostic and molecular processes for biological and medical applications.
The innovative method “Fluorimetry of Molecular Binding-FMB®” can be used for the specific detection of nucleic acids and biomarkers.
Our research, development, and industrial implementation activities at our Berlin location are conducted in close collaboration with the Fraunhofer Institute for Applied Polymer Research (IAP) and are supported by funding from the European Union under the European Regional Development Fund (ERDF) as well as the Investment Bank Berlin.